Cel-Sci Corporation (CVM) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Cel-Sci Corporation
Cel-Sci Corporation is led by CEO Geert R. Kersten, employs 43 people, headquartered in US, publicly traded since 1983.
Cel-Sci Corporation (CVM) stock trades at $1.64 with a market capitalization of $28.85M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.90, reflecting a net loss over the last twelve months, price-to-book of 2.55, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.89 and $10.70, and currently trades 84.7% below its 52-week high.
On profitability, Cel-Sci Corporation generates a return on equity (ROE) of -202.14% (negative, reflecting a net loss), return on capital employed of -136.92%.
Cel-Sci Corporation by the numbers, 2016–2025
Between 2016 and 2025 Cel-Sci Corporation reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-25.0M.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-22.0M.
Borrowings fell from $13.0M to $9.0M, cash from operations was $-17.0M in the latest year, positive in 0 of the last 10.
Return on equity has averaged -157.8% over five years, and was -156.3% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Cel-Sci Corporation (CVM) — frequently asked questions
What is Cel-Sci Corporation (CVM) stock price today?
Cel-Sci Corporation (CVM) is currently trading at $1.64, up 1.86% today.
What is CVM P/E ratio?
Cel-Sci Corporation's P/E ratio is -0.90. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is CVM return on equity (ROE)?
Cel-Sci Corporation's return on equity (ROE) is -202.14%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Cel-Sci Corporation's market cap?
Cel-Sci Corporation has a market capitalization of $28.85M.
Does CVM pay a dividend?
Cel-Sci Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does CVM carry?
Cel-Sci Corporation has a debt-to-equity ratio of 0.72. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is CVM's profit margin?
Cel-Sci Corporation reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is CVM in?
Cel-Sci Corporation is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is CVM listed on?
Cel-Sci Corporation trades on AMEX under the ticker CVM.
What is CVM's 52-week range?
Over the last year Cel-Sci Corporation has traded between $0.89 and $10.70.
Related Healthcare Stocks
Popular Stocks
Screens CVM currently matches
On the figures above, Cel-Sci Corporation passes the filters for 2 of our ready-made screens, among them Penny Stocks, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.